The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hospital Injectable Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Hospital Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hospital Injectable Drugs market size is estimated to be worth US$ 41580 million in 2021 and is forecast to a readjusted size of USD 56940 million by 2028 with a CAGR of 4.6% during review period. Oncology accounting for % of the Hospital Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Generic Sterile Injectables segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hospital Injectable Drugs include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), and Hikma Pharmaceuticals PLC, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hospital Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Market segment by Application, can be divided into
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market segment by players, this report covers
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hospital Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hospital Injectable Drugs, with revenue, gross margin and global market share of Hospital Injectable Drugs from 2019 to 2022.
Chapter 3, the Hospital Injectable Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hospital Injectable Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hospital Injectable Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
The Hospital Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hospital Injectable Drugs market size is estimated to be worth US$ 41580 million in 2021 and is forecast to a readjusted size of USD 56940 million by 2028 with a CAGR of 4.6% during review period. Oncology accounting for % of the Hospital Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Generic Sterile Injectables segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hospital Injectable Drugs include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), and Hikma Pharmaceuticals PLC, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hospital Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Market segment by Application, can be divided into
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market segment by players, this report covers
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hospital Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hospital Injectable Drugs, with revenue, gross margin and global market share of Hospital Injectable Drugs from 2019 to 2022.
Chapter 3, the Hospital Injectable Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hospital Injectable Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hospital Injectable Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Hospital Injectable Drugs
1.2 Classification of Hospital Injectable Drugs by Type
1.2.1 Overview: Global Hospital Injectable Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Hospital Injectable Drugs Revenue Market Share by Type in 2021
1.2.3 Generic Sterile Injectables
1.2.4 Sterile Intravenous (IV) Solutions
1.3 Global Hospital Injectable Drugs Market by Application
1.3.1 Overview: Global Hospital Injectable Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Global Hospital Injectable Drugs Market Size & Forecast
1.5 Global Hospital Injectable Drugs Market Size and Forecast by Region
1.5.1 Global Hospital Injectable Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Hospital Injectable Drugs Market Size by Region, (2017-2022)
1.5.3 North America Hospital Injectable Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Hospital Injectable Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Hospital Injectable Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Hospital Injectable Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Hospital Injectable Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hospital Injectable Drugs Market Drivers
1.6.2 Hospital Injectable Drugs Market Restraints
1.6.3 Hospital Injectable Drugs Trends Analysis
2 Company Profiles
2.1 Hospira (Pfizer Inc.)
2.1.1 Hospira (Pfizer Inc.) Details
2.1.2 Hospira (Pfizer Inc.) Major Business
2.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product and Solutions
2.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Hospira (Pfizer Inc.) Recent Developments and Future Plans
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Hospital Injectable Drugs Product and Solutions
2.2.4 Baxter Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Baxter Recent Developments and Future Plans
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Hospital Injectable Drugs Product and Solutions
2.3.4 Fresenius Kabi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Fresenius Kabi Recent Developments and Future Plans
2.4 Sandoz (Novartis)
2.4.1 Sandoz (Novartis) Details
2.4.2 Sandoz (Novartis) Major Business
2.4.3 Sandoz (Novartis) Hospital Injectable Drugs Product and Solutions
2.4.4 Sandoz (Novartis) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sandoz (Novartis) Recent Developments and Future Plans
2.5 Hikma Pharmaceuticals PLC
2.5.1 Hikma Pharmaceuticals PLC Details
2.5.2 Hikma Pharmaceuticals PLC Major Business
2.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product and Solutions
2.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Hikma Pharmaceuticals PLC Recent Developments and Future Plans
2.6 Dr. Reddy’s Laboratories Ltd
2.6.1 Dr. Reddy’s Laboratories Ltd Details
2.6.2 Dr. Reddy’s Laboratories Ltd Major Business
2.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product and Solutions
2.6.4 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.7 Grifols
2.7.1 Grifols Details
2.7.2 Grifols Major Business
2.7.3 Grifols Hospital Injectable Drugs Product and Solutions
2.7.4 Grifols Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Grifols Recent Developments and Future Plans
2.8 Nichi-Iko Group (Sagent)
2.8.1 Nichi-Iko Group (Sagent) Details
2.8.2 Nichi-Iko Group (Sagent) Major Business
2.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product and Solutions
2.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Nichi-Iko Group (Sagent) Recent Developments and Future Plans
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.9.4 Teva Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Teva Pharmaceutical Recent Developments and Future Plans
2.10 Otsuka
2.10.1 Otsuka Details
2.10.2 Otsuka Major Business
2.10.3 Otsuka Hospital Injectable Drugs Product and Solutions
2.10.4 Otsuka Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Otsuka Recent Developments and Future Plans
2.11 B.Braun
2.11.1 B.Braun Details
2.11.2 B.Braun Major Business
2.11.3 B.Braun Hospital Injectable Drugs Product and Solutions
2.11.4 B.Braun Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 B.Braun Recent Developments and Future Plans
2.12 JW Life Science
2.12.1 JW Life Science Details
2.12.2 JW Life Science Major Business
2.12.3 JW Life Science Hospital Injectable Drugs Product and Solutions
2.12.4 JW Life Science Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 JW Life Science Recent Developments and Future Plans
2.13 Auromedics
2.13.1 Auromedics Details
2.13.2 Auromedics Major Business
2.13.3 Auromedics Hospital Injectable Drugs Product and Solutions
2.13.4 Auromedics Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Auromedics Recent Developments and Future Plans
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Hospital Injectable Drugs Product and Solutions
2.14.4 Sanofi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sanofi Recent Developments and Future Plans
2.15 Gland Pharma
2.15.1 Gland Pharma Details
2.15.2 Gland Pharma Major Business
2.15.3 Gland Pharma Hospital Injectable Drugs Product and Solutions
2.15.4 Gland Pharma Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Gland Pharma Recent Developments and Future Plans
2.16 Endo International PLC
2.16.1 Endo International PLC Details
2.16.2 Endo International PLC Major Business
2.16.3 Endo International PLC Hospital Injectable Drugs Product and Solutions
2.16.4 Endo International PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Endo International PLC Recent Developments and Future Plans
2.17 Sichuan Kelun Pharmaceutical
2.17.1 Sichuan Kelun Pharmaceutical Details
2.17.2 Sichuan Kelun Pharmaceutical Major Business
2.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
2.18 Cisen Pharmaceutical
2.18.1 Cisen Pharmaceutical Details
2.18.2 Cisen Pharmaceutical Major Business
2.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Cisen Pharmaceutical Recent Developments and Future Plans
2.19 Shijiazhuang No. 4 Pharmaceutical
2.19.1 Shijiazhuang No. 4 Pharmaceutical Details
2.19.2 Shijiazhuang No. 4 Pharmaceutical Major Business
2.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments and Future Plans
2.20 Shandong Hualu Pharmaceutical
2.20.1 Shandong Hualu Pharmaceutical Details
2.20.2 Shandong Hualu Pharmaceutical Major Business
2.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Shandong Hualu Pharmaceutical Recent Developments and Future Plans
2.21 CR Double-Crane
2.21.1 CR Double-Crane Details
2.21.2 CR Double-Crane Major Business
2.21.3 CR Double-Crane Hospital Injectable Drugs Product and Solutions
2.21.4 CR Double-Crane Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 CR Double-Crane Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hospital Injectable Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Hospital Injectable Drugs Players Market Share in 2021
3.2.2 Top 10 Hospital Injectable Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Hospital Injectable Drugs Players Head Office, Products and Services Provided
3.4 Hospital Injectable Drugs Mergers & Acquisitions
3.5 Hospital Injectable Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hospital Injectable Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Hospital Injectable Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Hospital Injectable Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Hospital Injectable Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Hospital Injectable Drugs Revenue by Type (2017-2028)
6.2 North America Hospital Injectable Drugs Revenue by Application (2017-2028)
6.3 North America Hospital Injectable Drugs Market Size by Country
6.3.1 North America Hospital Injectable Drugs Revenue by Country (2017-2028)
6.3.2 United States Hospital Injectable Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Hospital Injectable Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Hospital Injectable Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Hospital Injectable Drugs Revenue by Type (2017-2028)
7.2 Europe Hospital Injectable Drugs Revenue by Application (2017-2028)
7.3 Europe Hospital Injectable Drugs Market Size by Country
7.3.1 Europe Hospital Injectable Drugs Revenue by Country (2017-2028)
7.3.2 Germany Hospital Injectable Drugs Market Size and Forecast (2017-2028)
7.3.3 France Hospital Injectable Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Hospital Injectable Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Hospital Injectable Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Hospital Injectable Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hospital Injectable Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Hospital Injectable Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Region
8.3.1 Asia-Pacific Hospital Injectable Drugs Revenue by Region (2017-2028)
8.3.2 China Hospital Injectable Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Hospital Injectable Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Hospital Injectable Drugs Market Size and Forecast (2017-2028)
8.3.5 India Hospital Injectable Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Hospital Injectable Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Hospital Injectable Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Hospital Injectable Drugs Revenue by Type (2017-2028)
9.2 South America Hospital Injectable Drugs Revenue by Application (2017-2028)
9.3 South America Hospital Injectable Drugs Market Size by Country
9.3.1 South America Hospital Injectable Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Hospital Injectable Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Hospital Injectable Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hospital Injectable Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Hospital Injectable Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Country
10.3.1 Middle East & Africa Hospital Injectable Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Hospital Injectable Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Hospital Injectable Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Hospital Injectable Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Hospital Injectable Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Hospital Injectable Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Hospital Injectable Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Hospital Injectable Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Hospital Injectable Drugs Revenue Market Share by Region (2023-2028)
Table 6. Hospira (Pfizer Inc.) Corporate Information, Head Office, and Major Competitors
Table 7. Hospira (Pfizer Inc.) Major Business
Table 8. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product and Solutions
Table 9. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Baxter Corporate Information, Head Office, and Major Competitors
Table 11. Baxter Major Business
Table 12. Baxter Hospital Injectable Drugs Product and Solutions
Table 13. Baxter Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 15. Fresenius Kabi Major Business
Table 16. Fresenius Kabi Hospital Injectable Drugs Product and Solutions
Table 17. Fresenius Kabi Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sandoz (Novartis) Corporate Information, Head Office, and Major Competitors
Table 19. Sandoz (Novartis) Major Business
Table 20. Sandoz (Novartis) Hospital Injectable Drugs Product and Solutions
Table 21. Sandoz (Novartis) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Hikma Pharmaceuticals PLC Corporate Information, Head Office, and Major Competitors
Table 23. Hikma Pharmaceuticals PLC Major Business
Table 24. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product and Solutions
Table 25. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Dr. Reddy’s Laboratories Ltd Corporate Information, Head Office, and Major Competitors
Table 27. Dr. Reddy’s Laboratories Ltd Major Business
Table 28. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product and Solutions
Table 29. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Grifols Corporate Information, Head Office, and Major Competitors
Table 31. Grifols Major Business
Table 32. Grifols Hospital Injectable Drugs Product and Solutions
Table 33. Grifols Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Nichi-Iko Group (Sagent) Corporate Information, Head Office, and Major Competitors
Table 35. Nichi-Iko Group (Sagent) Major Business
Table 36. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product and Solutions
Table 37. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 39. Teva Pharmaceutical Major Business
Table 40. Teva Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 41. Teva Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Otsuka Corporate Information, Head Office, and Major Competitors
Table 43. Otsuka Major Business
Table 44. Otsuka Hospital Injectable Drugs Product and Solutions
Table 45. Otsuka Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. B.Braun Corporate Information, Head Office, and Major Competitors
Table 47. B.Braun Major Business
Table 48. B.Braun Hospital Injectable Drugs Product and Solutions
Table 49. B.Braun Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. JW Life Science Corporate Information, Head Office, and Major Competitors
Table 51. JW Life Science Major Business
Table 52. JW Life Science Hospital Injectable Drugs Product and Solutions
Table 53. JW Life Science Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Auromedics Corporate Information, Head Office, and Major Competitors
Table 55. Auromedics Major Business
Table 56. Auromedics Hospital Injectable Drugs Product and Solutions
Table 57. Auromedics Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sanofi Corporate Information, Head Office, and Major Competitors
Table 59. Sanofi Major Business
Table 60. Sanofi Hospital Injectable Drugs Product and Solutions
Table 61. Sanofi Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Gland Pharma Corporate Information, Head Office, and Major Competitors
Table 63. Gland Pharma Major Business
Table 64. Gland Pharma Hospital Injectable Drugs Product and Solutions
Table 65. Gland Pharma Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Endo International PLC Corporate Information, Head Office, and Major Competitors
Table 67. Endo International PLC Major Business
Table 68. Endo International PLC Hospital Injectable Drugs Product and Solutions
Table 69. Endo International PLC Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Sichuan Kelun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 71. Sichuan Kelun Pharmaceutical Major Business
Table 72. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 73. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Cisen Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 75. Cisen Pharmaceutical Major Business
Table 76. Cisen Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 77. Cisen Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Shijiazhuang No. 4 Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 79. Shijiazhuang No. 4 Pharmaceutical Major Business
Table 80. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 81. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Shandong Hualu Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 83. Shandong Hualu Pharmaceutical Major Business
Table 84. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 85. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. CR Double-Crane Corporate Information, Head Office, and Major Competitors
Table 87. CR Double-Crane Major Business
Table 88. CR Double-Crane Hospital Injectable Drugs Product and Solutions
Table 89. CR Double-Crane Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Global Hospital Injectable Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 91. Global Hospital Injectable Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 92. Breakdown of Hospital Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Hospital Injectable Drugs Players Head Office, Products and Services Provided
Table 94. Hospital Injectable Drugs Mergers & Acquisitions in the Past Five Years
Table 95. Hospital Injectable Drugs New Entrants and Expansion Plans
Table 96. Global Hospital Injectable Drugs Revenue (USD Million) by Type (2017-2022)
Table 97. Global Hospital Injectable Drugs Revenue Share by Type (2017-2022)
Table 98. Global Hospital Injectable Drugs Revenue Forecast by Type (2023-2028)
Table 99. Global Hospital Injectable Drugs Revenue by Application (2017-2022)
Table 100. Global Hospital Injectable Drugs Revenue Forecast by Application (2023-2028)
Table 101. North America Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 102. North America Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 103. North America Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 104. North America Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 105. North America Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 106. North America Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 107. Europe Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 108. Europe Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 109. Europe Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 110. Europe Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 111. Europe Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 112. Europe Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 113. Asia-Pacific Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 114. Asia-Pacific Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 115. Asia-Pacific Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 116. Asia-Pacific Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 117. Asia-Pacific Hospital Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 118. Asia-Pacific Hospital Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 119. South America Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 120. South America Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 121. South America Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 122. South America Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 123. South America Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 124. South America Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 125. Middle East & Africa Hospital Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 126. Middle East & Africa Hospital Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 127. Middle East & Africa Hospital Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 128. Middle East & Africa Hospital Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 129. Middle East & Africa Hospital Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 130. Middle East & Africa Hospital Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Hospital Injectable Drugs Picture
Figure 2. Global Hospital Injectable Drugs Revenue Market Share by Type in 2021
Figure 3. Generic Sterile Injectables
Figure 4. Sterile Intravenous (IV) Solutions
Figure 5. Hospital Injectable Drugs Revenue Market Share by Application in 2021
Figure 6. Oncology Picture
Figure 7. Anesthesia Picture
Figure 8. Anti-Infectives Picture
Figure 9. Parenteral Nutrition Picture
Figure 10. Cardiovascular Diseases Picture
Figure 11. Global Hospital Injectable Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Hospital Injectable Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Hospital Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 14. Global Hospital Injectable Drugs Revenue Market Share by Region in 2021
Figure 15. North America Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Hospital Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Hospital Injectable Drugs Market Drivers
Figure 21. Hospital Injectable Drugs Market Restraints
Figure 22. Hospital Injectable Drugs Market Trends
Figure 23. Hospira (Pfizer Inc.) Recent Developments and Future Plans
Figure 24. Baxter Recent Developments and Future Plans
Figure 25. Fresenius Kabi Recent Developments and Future Plans
Figure 26. Sandoz (Novartis) Recent Developments and Future Plans
Figure 27. Hikma Pharmaceuticals PLC Recent Developments and Future Plans
Figure 28. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
Figure 29. Grifols Recent Developments and Future Plans
Figure 30. Nichi-Iko Group (Sagent) Recent Developments and Future Plans
Figure 31. Teva Pharmaceutical Recent Developments and Future Plans
Figure 32. Otsuka Recent Developments and Future Plans
Figure 33. B.Braun Recent Developments and Future Plans
Figure 34. JW Life Science Recent Developments and Future Plans
Figure 35. Auromedics Recent Developments and Future Plans
Figure 36. Sanofi Recent Developments and Future Plans
Figure 37. Gland Pharma Recent Developments and Future Plans
Figure 38. Endo International PLC Recent Developments and Future Plans
Figure 39. Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
Figure 40. Cisen Pharmaceutical Recent Developments and Future Plans
Figure 41. Shijiazhuang No. 4 Pharmaceutical Recent Developments and Future Plans
Figure 42. Shandong Hualu Pharmaceutical Recent Developments and Future Plans
Figure 43. CR Double-Crane Recent Developments and Future Plans
Figure 44. Global Hospital Injectable Drugs Revenue Share by Players in 2021
Figure 45. Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 46. Global Top 3 Players Hospital Injectable Drugs Revenue Market Share in 2021
Figure 47. Global Top 10 Players Hospital Injectable Drugs Revenue Market Share in 2021
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 49. Global Hospital Injectable Drugs Revenue Share by Type in 2021
Figure 50. Global Hospital Injectable Drugs Market Share Forecast by Type (2023-2028)
Figure 51. Global Hospital Injectable Drugs Revenue Share by Application in 2021
Figure 52. Global Hospital Injectable Drugs Market Share Forecast by Application (2023-2028)
Figure 53. North America Hospital Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 54. North America Hospital Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 55. North America Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 56. United States Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Canada Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Mexico Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Europe Hospital Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 60. Europe Hospital Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 61. Europe Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 62. Germany Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. France Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. United Kingdom Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Russia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Italy Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Asia-Pacific Hospital Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 68. Asia-Pacific Hospital Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 69. Asia-Pacific Hospital Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 70. China Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Japan Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Korea Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. India Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Southeast Asia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Australia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South America Hospital Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 77. South America Hospital Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 78. South America Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 79. Brazil Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Argentina Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 84. Turkey Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Saudi Arabia Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. UAE Hospital Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
